Owens David has filed 21 insider transactions across 1 company since September 2022.
Most recent transaction: a grant/award of 1000000 shares of Nexalin Technology, Inc. ($NXL) on December 19, 2025.
Activity breakdown: 13 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 19, 2025 | Nexalin Technology, Inc. | $NXL | Owens David | Chief Medical Officer | A | Stock Option (right to buy)* | 1000000 | $0.00 | 2,484,809.0000 | 18,651,939 | 67.35% | 5.36% |
| Sept. 29, 2025 | Nexalin Technology, Inc. | $NXL | Owens David | Chief Medical Officer | A | Common stock | 36459 | $0.00 | 191,252.0000 | 13,303,523 | 23.55% | 0.27% |
| Sept. 12, 2025 | Nexalin Technology, Inc. | $NXL | Owens David | Chief Medical Officer | A | Stock Option (right to buy) | 100000 | $0.00 | 1,484,809.0000 | 13,303,523 | 7.22% | 0.75% |
| Sept. 12, 2025 | Nexalin Technology, Inc. | $NXL | Owens David | Chief Medical Officer | A | Stock Option (right to buy) | 203125 | $0.00 | 1,384,809.0000 | 13,303,523 | 17.19% | 1.53% |
| Feb. 26, 2025 | Nexalin Technology, Inc. | $NXL | Owens David | Chief Medical Officer | A | Stock Option (right to buy) | 139821 | $0.00 | 139,821.0000 | 0 | 9999.99% | 0.00% |
| Feb. 26, 2025 | Nexalin Technology, Inc. | $NXL | Owens David | Chief Medical Officer | A | Stock Option (right to buy) | 654363 | $0.00 | 794,184.0000 | 0 | 468.00% | 0.00% |
| Feb. 26, 2025 | Nexalin Technology, Inc. | $NXL | Owens David | Chief Medical Officer | A | Stock Option (right to buy) | 125000 | $0.00 | 919,184.0000 | 0 | 15.74% | 0.00% |
| Feb. 4, 2025 | Nexalin Technology, Inc. | $NXL | Owens David | Chief Medical Officer | P | Common stock | 1000 | $3.10 | 155,793.0000 | 0 | 0.65% | 0.00% |
| Feb. 4, 2025 | Nexalin Technology, Inc. | $NXL | Owens David | Chief Medical Officer | P | Common stock | 1000 | $2.98 | 154,793.0000 | 0 | 0.65% | 0.00% |
| Jan. 28, 2025 | Nexalin Technology, Inc. | $NXL | Owens David | Chief Medical Officer | P | Common stock | 1500 | $2.70 | 153,793.0000 | 0 | 0.98% | 0.00% |
| Nov. 7, 2024 | Nexalin Technology, Inc. | $NXL | Owens David | Chief Medical Officer | A | Stock Option (right to buy) | 262500 | $0.00 | 262,500.0000 | 0 | 9999.99% | 0.00% |
| Dec. 20, 2024 | Nexalin Technology, Inc. | $NXL | Owens David | Chief Medical Officer | P | Common stock | 1000 | $2.75 | 149,293.0000 | 0 | 0.67% | 0.00% |
| Jan. 13, 2025 | Nexalin Technology, Inc. | $NXL | Owens David | Chief Medical Officer | P | Common stock | 2000 | $2.50 | 151,293.0000 | 0 | 1.34% | 0.00% |
| Jan. 23, 2025 | Nexalin Technology, Inc. | $NXL | Owens David | Chief Medical Officer | P | Common stock | 1000 | $2.70 | 152,293.0000 | 0 | 0.66% | 0.00% |
| Oct. 28, 2024 | Nexalin Technology, Inc. | $NXL | Owens David | Chief Medical Officer | P | Common stock | 500 | $2.19 | 148,293.0000 | 0 | 0.34% | 0.00% |
| Aug. 13, 2024 | Nexalin Technology, Inc. | $NXL | Owens David | Chief Medical Officer | P | Common stock | 1000 | $0.95 | 147,793.0000 | 0 | 0.68% | 0.00% |
| June 28, 2024 | Nexalin Technology, Inc. | $NXL | Owens David | Chief Medical Officer | P | Common stock | 1000 | $1.75 | 146,793.0000 | 0 | 0.69% | 0.00% |
| June 18, 2024 | Nexalin Technology, Inc. | $NXL | Owens David | Chief Medical Officer | P | Common stock | 1619 | $0.71 | 145,793.0000 | 0 | 1.12% | 0.00% |
| June 10, 2024 | Nexalin Technology, Inc. | $NXL | Owens David | Chief Medical Officer | P | Common stock | 1000 | $0.62 | 144,174.0000 | 0 | 0.70% | 0.00% |
| June 10, 2024 | Nexalin Technology, Inc. | $NXL | Owens David | Chief Medical Officer | P | Common stock | 2000 | $0.65 | 143,174.0000 | 0 | 1.42% | 0.00% |
| Sept. 16, 2022 | Nexalin Technology, Inc. | $NXL | Owens David | Chief Medical Officer | P | Common stock warrants | 2500 | $0.40 | 2,500.0000 | 0 | 9999.99% | 0.00% |